Why the study?
Does a pharmacy-led Transition of Care intervention reduce unplanned readmissions due to medication harm within 30 days in patients following acute type 1 myocardial infarction or coronary revascularisation procedures compared to usual care?
Population
Patients following acute type 1 myocardial infarction or coronary revascularisation procedures
Comparison
Pharmacy-led Transition of Care intervention… vs Retrospective historical cohort receiving usual…
Design
Other
Follow-up
30 days
Authors
Loading...
This theoretical paper outlines a multidimensional implementation science approach to design and evaluate a pharmacy-led transition of care intervention for high-risk cardiology patients in Australia.
Does a pharmacy-led Transition of Care intervention reduce unplanned readmissions due to medication harm within 30 days in patients following acute type 1 myocardial infarction or coronary revascularisation procedures compared to usual care?
This theoretical paper outlines a multidimensional implementation science approach to design and evaluate a pharmacy-led transition of care intervention for high-risk cardiology patients in Australia.
Wilkinson et al. (2026) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: